Wilding JPH, Kwan AYM, Maldonado JM, Wang H, Rasouli N (2022) Tirzepatide induces weight loss in patients with type 2 diabetes regardless of baseline BMI: a post hoc analysis of SURPASS-1 through SURPASS-5 studies
Perform the reconstitution and handling in a clean, draft-free environment to minimize airborne contaminants
Patients with inflammatory arthritis conditions should continue disease-modifying treatments as prescribed by their rheumatologist
However, there is limited clinical experience with dulaglutide in liver disease so caution should be used
It decreases leptin, the satiety hormone, by a similar amount
However, certain metabolic and clinical patterns may suggest suboptimal GLP-1 activity, though these signs are non-specific and can result from numerous other conditions